Physicians' reported needs of drug information at point of care in Sweden

Pia Bastholm Rahmner*, Birgit Eiermann, Seher Korkmaz, Lars L. Gustafsson, Magnus Gruven, Simon Maxwell, Hans-Georg Eichle, Aniko Veg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

AIMS
Relevant and easily accessible drug information at point-of-care is essential for physicians' decision making when prescribing. However, the information available by using Clinical Decision Support Systems (CDSSs) often does not meet physicians' requirements. The Summary of Product Characteristics (SmPC) is statutory information about drugs. However, the current structure, content and format of SmPCs make it difficult to incorporate them into CDSSs and link them to relevant patient information from the Electronic Health Records. The aim of the study was to evaluate the perceived needs for drug information among physicians in Sweden.

METHODS
We recruited three focus group discussions with 18 physicians covering different specialities. The information from the groups was combined with a questionnaire administered at the beginning of the group discussions.

RESULTS
Physicians reported their needs for knowledge databases at the point of drug prescribing. This included more consistent information about existing and new drugs. They also wished to receive automatically generated alerts for severe drug-drug interactions and adverse effects, and to have functions for calculating glomerular filtration rate to enable appropriate dose adjustments to be made for elderly patients and those with impaired renal function. Additionally, features enhancing electronic communication with colleagues and making drug information more searchable were suggested.

CONCLUSIONS
The results from the current study showed the need for knowledge databases which provide consistent information about new and existing drugs. Most of the required information from physicians appeared to be possible to transfer from current SmPCs to CDSSs. However, inconsistencies in the SmPC information have to be reduced to enhance their utility.

Original languageEnglish
Pages (from-to)115-125
Number of pages11
JournalBritish Journal of Clinical Pharmacology
Volume73
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • DESIGN
  • MANAGEMENT
  • drug information
  • QUALITY
  • PRODUCT CHARACTERISTICS
  • medical informatics
  • STOCKHOLM
  • focus group discussions
  • ORDER ENTRY SYSTEMS
  • ERRORS
  • KNOWLEDGE
  • drug labelling
  • RECOMMENDATIONS
  • CLINICAL DECISION-SUPPORT
  • decision support systems
  • health services needs and demand

Cite this